Ida Laurén
PhD student at Department of Pharmacy; Biopharmaceuticals; Immunonkologi
- E-mail:
- ida.lauren@uu.se
- Visiting address:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postal address:
- Box 580
751 23 UPPSALA
Postdoctoral position at Department of Public Health and Caring Sciences; Molecular Geriatrics / Rudbeck laboratory
- E-mail:
- ida.lauren@uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
- Postal address:
- Rudbecklaboratoriet
751 85 Uppsala

Publications
Recent publications
-
Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks
Part of npj Precision Oncology, 2026
- DOI for Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks
- Download full text (pdf) of Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks
-
Part of International Journal of Biological Macromolecules, 2026
- DOI for Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange
- Download full text (pdf) of Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange
-
2025
-
Part of Nature Communications, 2024
- DOI for A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice
- Download full text (pdf) of A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice
-
Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies
Part of ChemBioChem, 2023
- DOI for Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies
- Download full text (pdf) of Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies
All publications
Articles in journal
-
Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks
Part of npj Precision Oncology, 2026
- DOI for Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks
- Download full text (pdf) of Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks
-
Part of International Journal of Biological Macromolecules, 2026
- DOI for Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange
- Download full text (pdf) of Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange
-
Part of Nature Communications, 2024
- DOI for A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice
- Download full text (pdf) of A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice
-
Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies
Part of ChemBioChem, 2023
- DOI for Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies
- Download full text (pdf) of Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies
-
Part of Advanced Therapeutics, 2022
- DOI for An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
- Download full text (pdf) of An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
-
Part of JAMA Network Open, 2022
- DOI for Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab
- Download full text (pdf) of Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab